Global Blood Banking and Blood Products Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Blood Banking and Blood Products Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Blood Banking and Blood Products market size was valued at US$ 55120 million in 2024 and is forecast to a readjusted size of USD 87950 million by 2031 with a CAGR of 6.9% during review period.

Blood banking is the process that takes place in the lab to make sure that donated blood, or blood products, are safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood. This includes: whole blood; blood components; and plasma derivatives. Whole blood is not commonly used in transfusion medicine.

Blood products refer to various human plasma protein products, including albumin, immunoglobulin, coagulation factors, etc. The raw material of blood products is plasma. 92% - 93% of human plasma is water, and only 7% - 8% is protein. Blood products are made by separating and purifying this part of protein.

The primary driver of the blood banking market is the increasing prevalence of chronic diseases and the rising number of surgical procedures globally. Conditions such as cancer, anemia, and trauma often require blood transfusions, boosting the demand for blood and blood products. Additionally, advancements in medical technology, such as improved blood preservation techniques and the development of blood substitutes, have enhanced the efficiency of blood banking systems, further contributing to market growth. One major challenge in the blood banking market is the risk of blood contamination and the transmission of infectious diseases. Despite stringent screening processes, there remains a possibility of contamination, especially in regions with less advanced healthcare systems. Furthermore, the high cost of blood testing and the maintenance of blood banks, coupled with the difficulty in ensuring a consistent blood supply due to low donation rates in some areas, presents significant obstacles to market expansion.

The growing prevalence of immunodeficiency disorders, hemophilia, and other chronic diseases that require plasma-derived therapies is a key driver of the blood product market. Blood products, such as immunoglobulins, clotting factors, and albumin, are essential in treating conditions where patients have compromised immune systems or bleeding disorders. Furthermore, the increasing use of plasma products in emergency care and surgical procedures, along with advancements in fractionation technologies, is boosting market demand. A major challenge in the blood product market is the high cost and complexity of the plasma collection and fractionation process. The production of blood products requires strict regulatory compliance and advanced facilities to ensure the purity and safety of these therapies, driving up costs. Additionally, fluctuations in plasma donation rates and the need for extensive screening to prevent contamination or the spread of infectious diseases can lead to supply shortages, especially in regions with underdeveloped healthcare infrastructure.

This report is a detailed and comprehensive analysis for global Blood Banking and Blood Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Blood Banking and Blood Products market size and forecasts, in consumption value ($ Million), 2020-2031

Global Blood Banking and Blood Products market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Blood Banking and Blood Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Blood Banking and Blood Products market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Blood Banking and Blood Products

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Blood Banking and Blood Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include America’s Blood Centers, Japan Red Cross Society, American Red Cross, Australia Red Cross, Red Cross Society of China, NHS Blood and Transplant, New York Blood Center, Canadian Blood Services, Sanquin Blood Supply Foundation, Blood Bank of Alaska, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Blood Banking and Blood Products market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
RBCs
Plts
Plasma
Whole Blood
Plasma Fractionation Products

Market segment by Application
Hospital
Clinic
Retail Pharmacy
Others

Market segment by players, this report covers
America’s Blood Centers
Japan Red Cross Society
American Red Cross
Australia Red Cross
Red Cross Society of China
NHS Blood and Transplant
New York Blood Center
Canadian Blood Services
Sanquin Blood Supply Foundation
Blood Bank of Alaska
Vitalant
National Blood Transfusion Council
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Blood Banking and Blood Products product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Blood Banking and Blood Products, with revenue, gross margin, and global market share of Blood Banking and Blood Products from 2020 to 2025.

Chapter 3, the Blood Banking and Blood Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Blood Banking and Blood Products market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Banking and Blood Products.

Chapter 13, to describe Blood Banking and Blood Products research findings and conclusion.